Surgery – Means for introducing or removing material from body for... – Treating material introduced into or removed from body...
Reexamination Certificate
2000-01-05
2002-10-22
Nguyen, Anhtuan T. (Department: 3763)
Surgery
Means for introducing or removing material from body for...
Treating material introduced into or removed from body...
C424S009360
Reexamination Certificate
active
06468244
ABSTRACT:
BACKGROUND AND DESCRIPTION OF THE INVENTION
1. Technical Background
The present invention relates generally to medical devices, and more particularly to a catheter having a portion coated with fullerenes, and therapeutic methods for making and using the same.
2. Discussion
Medical catheters are used in a variety of therapeutic applications, including esophageal catheters, urinary catheters, and intravascular catheters for procedures such as angioplasty. By way of example, the present invention will be described in relation to vascular catheters, and in particular intravascular balloon catheters. However, it should be understood that the present invention relates to any catheter or catheter system incorporating fullerenes, and is not limited to balloon catheters or any other type of catheter.
For example, most balloon catheters have a relatively long and flexible tubular shaft defining one or more passages, called lumens, an inflatable balloon at a forward or distal end connected to an inflation lumen extending through the shaft, leading to a proximal hub at the other end for connecting the shaft lumens to various equipment. Examples of this type of balloon catheter are shown in U.S. Pat. No. 5,304,197, entitled “Balloons For Medical Devices And Fabrication Thereof,” issued to Pinchuk et al. on Apr. 19th, 1994, and U.S. Pat. No. 5,370,615, entitled “Balloons Catheter For Angioplasty,” issued to Johnson on Dec. 6, 1994.
A common treatment method for using such a balloon catheter is to advance the catheter into the body of a patient, by directing the catheter distal end through an incision and along a body passage, until the balloon is located within the desired site. The term “desired site” refers to the location in the patient's body currently selected for treatment by a health care professional. After the balloon is disposed within the desired site, it can be selectively inflated for one of two basic purposes. First, the balloon may be used to temporarily block or occlude the body passage at a relatively low pressure, as in the case of a balloon made of elastic or compliant material. Second, the balloon can press outward on the wall of the body passage at relatively high pressure to a relatively constant diameter, as in the case of an inelastic or non-compliant balloon material.
This outward pressing of a constriction or narrowing at the desired site in a body passage is intended to partially or completely re-open or dilate that passageway or lumen, increasing its inner diameter or cross-sectional area. In the case of a blood vessel, this procedure is referred to as angioplasty, and it encourages greater blood flow through the newly expanded vessel. The narrowing of the lumen is called a lesion or stenosis, and may be formed of hard plaque or viscous thrombus.
Nearly one million angioplasties were performed worldwide in 1997 to treat vascular disease, including coronary, neurological and peripheral blood vessels partially or totally blocked or narrowed by a stenosis.
Unfortunately, within approximately six months after angioplasty, the lumen at the angioplasty site may re-close or narrow again. This phenomenon is called restenosis, and may occur in as many as 35% of percutaneous transluminal angioplasty patients. Restenosis may require an additional procedure, such as another angioplasty, drug therapy treatment, or surgery including bypass graft. It is of course desirable to prevent or limit the occurrence of restenosis, especially since some patients may not be preferred candidates for another interventional treatment.
One method of limiting restenosis is to permanently implant a cylindrical metal scaffold, referred to as a stent, into the vessel to hold the lumen open and improve blood flow. The presence of a stent tends to keep the blood vessel open longer, but their use can be limited by various factors, including size and location of the blood vessel, a complicated or tortuous vessel pathway, etc. Also, even a vessel with a stent may eventually develop restenosis.
A possible cause for restenosis is the proliferation of smooth muscle cells at the site of the lesion. In other words, a site where tissue has grown in the past, in the form of a collection of smooth muscle cells before angioplasty, may tend to accumulate cells at that location again. Accordingly, it is desirable to prevent or limit accumulation of these fast-replicating smooth muscle cells, in an effort to prevent restenosis.
It has been discovered that the local presence of oxygen radicals (or other reactive oxygen species) in the vicinity of a stenosis may kill smooth muscle cells, or inhibit their future accumulation. It is therefore desirable to provide a system or device and method for generating these oxygen radicals at the desired site within the patient's body.
It is possible that the presence of a newly discovered type of material may generate oxygen radicals or other reactive oxygen species when activated by exposure to light. This new class of materials is called “fullerenes,” and they represent a previously unknown third form or allotrope of carbon. The other two carbon allotropes have been known for most of recorded history: graphite and diamond.
The family of fullerene materials includes a symmetrical hollow spherical molecule containing 60 carbon atoms (C
60
), and also various asymmetrical forms, including carbon atoms in groups of 70, 76, 78, 82, 84, 90, and 96. The entire class of materials is named after the designer of the geodesic dome, R. Buckminster Fuller, because the spherical C
60
looks like a geodesic dome or soccer ball. Accordingly, C
60
is called Buckminsterfullerene or “bucky balls.” The bucky ball is the only molecule of a single atom that forms a hollow spheroid shape, in geometric terms a “truncated icosahedon.”
In 1985, Richard Smalley, Robert Curl, and Harold Kroto, won the Nobel Prize in chemistry for their work with fullerenes. This work led to various articles and patents, including U.S. Pat. No. 5,300,203, entitled “Process For Making Fullerenes By The Laser Evaporation Of Carbon,” issued to Smalley on Apr. 5, 1994. A variety of compositions and different applications for fullerenes are described in many patents, including U.S. Pat. No. 5,172,278, entitled “Buckminsterfullerenes For Optical Limiters,” issued to Tutt on Dec. 15, 1992, and U.S. Pat. No. 5,561,026, entitled “Photosensitive Materials Comprising Fullerenes,” issued to Aoki on Oct. 1, 1996.
It is accordingly a general object of the present invention to provide a catheter system incorporating fullerenes for performing or facilitating a medical procedure.
REFERENCES:
patent: 5006119 (1991-04-01), Acker et al.
patent: 5090959 (1992-02-01), Samson et al.
patent: 5092841 (1992-03-01), Spears
patent: 5370608 (1994-12-01), Sahota et al.
patent: 5688486 (1997-11-01), Watson
patent: 0 770 577 (1997-05-01), None
patent: 95/21637 (1995-08-01), None
A.W. Jensen, et al., “Biological Applications Of Fullerenes”; Biorganic & Medical Chemistry, Elsevier Science Ltd, GB; vol. 4, No. 6, 1996, pp. 767-779; XP000964594; Department of Chemistry, New York University, 100 Washington Square East, New York, NY 10003.
Huei-Chen Huang, et al., “Antiproliferative Effect Of Polyhydroxylated C60 On Vascular Smooth Muscle Cells”; Electrochemical Society Proceedings, Electrochemical Society; vol. 3, 1996, pp. 403-410, XP000964676; Pennington, NJ.
Leone James E.
Narayanan Pallassana V.
Montgomery Michael W.
Nguyen Anhtuan T.
LandOfFree
Catheter system having fullerenes and method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Catheter system having fullerenes and method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Catheter system having fullerenes and method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2923175